Benzinga.com27 天
Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant ...
TA-TMA is a complication in adult and pediatric hematopoietic stem cell transplantation (HSCT). The analysis compared overall survival in the 28 TA-TMA patients in OMS721-TMA-001, Omeros ...
Seeking Alpha28 天
Omeros jumps as lead drug succeeds in pivotal trial for blood transplant patients
Shares of Omeros Corporation (NASDAQ:OMER) climbed ~55% in the morning hours on Thursday after ... (TA-TMA), a complication of hematopoietic stem cell transplantation (HSCT).